Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, +232

The Lancet

EpidemiologyCancer EpidemiologyMedicineGlobal HealthEpidemiology Of Cancer +9

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Loretta J. Nastoupil, Michael D. Jain, Lei Feng, +25

Journal of Clinical Oncology

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

Austin J. Sim, Michael D. Jain, Nicholas Figura, +13

International Journal of Radiation Oncology*Biology*Physics

Bridging StrategyLymphoid NeoplasiaRadiation TherapyAxicabtagene CiloleucelMedicine +5

Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy

Mark Hamilton, Takeshi Sugio, Troy Noordenbos, +14

New England Journal of Medicine

Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium

Yucai Wang, Preetesh Jain, Frederick L. Locke, +26

Journal of Clinical Oncology

Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial

Matthew J. Frank, Nasheed Hossain, Ali Bukhari, +15

Journal of Clinical Oncology

Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience

Loretta J. Nastoupil, Michael D. Jain, Jay Y. Spiegel, +23

Blood

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

Franck Morschhauser, Saurabh Dahiya, M. Lia Palomba, +30

Nature Medicine

Treatment of Cerebral Radiation Necrosis With Bevacizumab

Neda H. Sadraei, Saurabh Dahiya, Samuel T. Chao, +7

American Journal of Clinical Oncology

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Mahmoud Elsawy, Julio C. Chávez, Irit Avivi, +28

Blood

Patient-reported OutcomesImmunologyPathologyImmunotherapyHematological Malignancy +17